This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Print Page   |   Contact Us   |   Sign In   |   Register
Community Search
CASSS Community News - November 7, 2019
Share |

Don't miss a new Member Spotlight on Andy Weiskopf! The Member Spotlight is an ongoing Q&A series focused on getting to know the CASSS community.


Member Spotlight: Andy Weiskopf,
Vice President, CMC Regulatory Affairs at Sana Biotechnology

The Member Spotlight is an ongoing Q&A series focused on getting to know the CASSS community. Today’s spotlight shines on Andy Weiskopf, Vice President, CMC Regulatory Affairs at Sana Biotechnology.

Q. What famous person (dead or alive) would you choose to have dinner with? Why?
Tough question! I guess I’d love to spend some time with Lin-Manuel Miranda and learn about his creative process. I admire him not only because of the brilliance and originality of his work, but also how relentlessly and genuinely positive he is. His Twitter feed is a wonderful antidote to… well, just about everything else on Twitter

Q. What would people be surprised to know about you?
I can play the oboe: played it for 9 years but stopped after high school.

Read more about Andy HERE.

See What’s Happening at WCBP 2020 Plenary Session Updates

The plenary sessions are now confirmed for WCBP 2020. View confirmed speakers, talk titles and session abstracts.

Space at WCBP is limited! Register today to secure your spot.

Northeast Regional Forum Registration Closing

CMC Strategies for Novel Biologic Modalities
– Blending External and Internal Development

Monday, November 18, 2019
Pfizer, Inc.

Discussion will include effective management of contract organizations including risk mitigation and technical capabilities. If you outsource any components of drug development for new modalities, you don’t want to miss this this interactive panel and opportunity to participate in roundtable discussion. To view the full program, click here.

Registration ends Friday, November 8, 2019. Due to security restrictions there will be NO ON-SITE registrations for this program.

Registration for the DC Area Scientific Discussion Group is Closing Soon

Join the CASSS DC Area Discussion on November 21, 2019 for an afternoon of discussion on NIST Science: Next Generation Sequencing and Gene Editing in Support of Biologicals Development and Control.

Featured Speakers

Genome Editing:
What It Is, What It Can Do,
and How We Understand What We Have Done

Samantha Maragh, NIST

Genome in a Bottle:
So You’ve Sequenced
a Genome – How Well
Did You Do?

Justin Zook, NIST

Upcoming CASSS Meetings






more Calendar

9/14/2020 » 9/17/2020
Mass Spec 2020

9/28/2020 » 10/1/2020
CE Pharm 2020

Membership Software Powered by YourMembership  ::  Legal